All | Women | Men | |
---|---|---|---|
n=605 | n=448 | n=157 | |
European high-risk area RA modified SCORE | |||
Risk SCORE | 2 (1, 4) | 2 (1, 3) | 4 (3, 7) |
Low/moderate risk | 483 (79.8%) | 397 (88.6%) | 86 (54.8%) |
High risk | 101(16.7%) | 48 (10.7%) | 53 (33.8%) |
Very high risk | 21 (3.5%) | 3 (0.7%) | 18 (11.5%) |
European low-risk area SCORE | |||
Low/moderate risk | 529 (87.4%) | 426 (95.1%) | 103 (65.6%) |
High risk | 67 (11.1%) | 21 (4.7%) | 46 (29.3%) |
Very high risk | 9 (1.5%) | 1 (0.2%) | 8 (5.1%) |
European low-risk area RA modified SCORE | |||
Risk SCORE | 2 (1, 4) | 1.5 (1, 3) | 4 (2, 6) |
Low/moderate risk | 507 (83.8%) | 417 (93.1%) | 90 (57.3%) |
High risk | 77 (12.7%) | 30 (6.7%) | 47 (29.9%) |
Very high risk | 21 (3.5%) | 1 (0.2%) | 20 (12.7%) |
Median and (IQR). The number of patients without known DM and CVD are reported for low/moderate risk (<5%), high risk (5 ≤high risk <10%) and very high risk (≥10%) and the percentages of the population without DM and CVD that we obtained a risk score for and stratified by gender. For gender-specific numbers, the percentages are calculated as the share of the female or male population with no known DM and CVD when we have obtained a risk score.
CVD, cardiovascular disease; DM, diabetes mellitus; RA, rheumatoid arthritis.